Lumidyne Technologies
Lumidyne Technologies–Commercialization of next-generation fluorescent probes with enhanced brightness and photostability across the visible spectrum. Lumidyne Technologies Team: Roger Altman Scott Blanchard
Read MoreDiamond Nanotechnologies
Diamond Nanotechnologies is developing a game-changing tool for neural activity imaging. Our goal is to enable breakthroughs in neuroscience and accelerate drug discovery and development. Diamond Nanotechnologies Team: Ophir Gaathon
Read MoreInVivo Analytics
InVivo Analytics – Our molecular imaging animal model and image processing algorithms allow for the non-invasive, real-time visualization of efficacy and safety studies in models of human disease. InVivo Analytics Team: Neal Paragas
Read MoreImmunovENT
ImmunovENT re-invents allergy diagnostics with the Local Allergy Mucosal Brush (LAMB) Test, which identifies local antigen-specific igE not found by skin or blood testing. ImmunovENT Team: Kate Rochlin
Read MoreSkinAxis
SkinAxis develops and provides an advanced 3D skin technologies for validation and discovery of drugs and cosmetic active ingredients in physiologically relevant conditions. SkinAxis Team: Arevik Mosoian Luca Gusella Elena Fedorov
Read MoreOptologix
Optologix — Our product uses light to activate gene expression in cells and animals, allowing for nontoxic, rapid, precisely timed and localized induction unmatched by chemical-based methods. Optologix Team: Kevin Gardner Laura Motta-Mena
Read MoreSveikatal
Sveikatal, is focused on the management of oral cancer using a novel retinoid therapy, which acts through pathways controlled by Vitamin A and complements current therapies. Sveikatal Team: John Wagner, PhD Amy Chen, CFO
Read MoreNomoCan Pharmaceuticals
Utilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer. NomoCan Pharmaceuticals Team: Ehsan Sarafraz-Yazdi, PhD Kamyar Neshvadian, FRM
Read MoreMassive Bio
Massive Bio provides cutting-edge concierge advisory services for precision oncology to cancer patients treated at community practices. Massive Bio Team: Selin Kurnaz, PhD. – CEO
Read MoreVitrisa Theraputics
Platform technology for rapid development of highly stable, high affinity clinic ready ligands called aptamers. Vitrisa Theraputics Team: Arijit Bhowmick Matthew Levy
Read More